Clinical benefits of a consistent reduction in blood pressure

Journal of Hypertension, Supplement

Volumn 16, Issue 6, 1998, Pages

  Mancia, Giuseppe ^a   Cattaneo, Bianca M ^b   Omboni, Stefano ^c   Grassi, Guido ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c IRCSS Auxologico Italiano   (Italy)

Author keywords

Ambulatory blood pressure monitoring; Antihypertensive treatment; Calcium antagonists; Clinical trials

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; DOSE TIME EFFECT RELATION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHRONIC DISEASE; CONTROLLED CLINICAL TRIALS; DEATH; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031783415     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Kannel WB. Importance of hypertension as a major risk factor in cardiovascular disease. In: Genest G, Koiw E, Kuchel D (editors): Hypertension. New York: McGraw Hill; 1977. pp. 888-910.
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
3. Hansson L. The J-shaped curve and how far should blood pressure be lowered. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysiology, diagnosis and management, 2nd Edition. New York: Raven Press; 1995. pp. 2765-2770.
4. Mancia G, Grassi G. Considerations on current and future trials in hypertension. Blood Press 1996; 5:327-332.
5. Mancia G, Grassi G. Combination treatment in antihypertensive drug trials [Editorial]. Cardiovasc Drugs Ther 1997; 11:517-518.
6. WHO/ISH Guidelines Sub-Committee. 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/ International Society of Hypertension meeting. J Hypertens 1993; 11:905-918.
7. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 1996; 93:697-703.
8. MacMahon S, Rodgers A. The effects of antihypertensive treatment on vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol 1994:4:265-271.
9. Isles CG, Walker LM, Beevers GD, Brown 1, Cameron HL, Clarke J, et al. Mortality of patients of the Glasgow Blood Pressure Clinic. J Hypertens 1986;4:141-156.
10. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large database. Blood Press 1995; 4:148-156.
11. Mancia G, Di Rienzo M, Parati G. Ambulatory blood pressure monitoring use in hypertension research and clinical practice. Hypertension 1993; 21:510-524.
12. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. J Am Med Assoc 1983; 249:2792-2796.
13. Mancia G, Zanchetti A, on behalf of the Sample Study Group. Importance of treatment-induced reduction of ambulatory blood pressure for regression of left ventricular hypertrophy in hypertension: the Sample study. Circulation 1997; 95:1464-1470.
14. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2446.
15. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood pressure control in the hypertensive population. Lancet 1997; 349:454-457.